股票行情快报:联影医疗(688271)1月26日主力资金净买入1.04亿元

Core Viewpoint - The stock of United Imaging Healthcare (688271) has shown a slight increase, with significant institutional interest and positive financial performance indicators, suggesting potential growth in the medical device sector [1][2][3]. Financial Performance - As of January 26, 2026, United Imaging Healthcare's stock closed at 133.95 yuan, with a 0.32% increase and a trading volume of 95,800 hands, amounting to a total transaction value of 1.285 billion yuan [1]. - In the last five days, the company experienced a net inflow of 104 million yuan from main funds, representing 8.1% of the total transaction value, while retail investors saw a net outflow of approximately 74.99 million yuan [1]. - For the first three quarters of 2025, the company reported a main business revenue of 8.859 billion yuan, a year-on-year increase of 27.39%, and a net profit of 1.12 billion yuan, up 66.91% year-on-year [2]. Industry Comparison - United Imaging Healthcare's total market capitalization stands at 110.396 billion yuan, ranking second in the medical device industry, while its net assets of 20.805 billion yuan rank third [2]. - The company's net profit margin is 12.44%, which is higher than the industry average of 9.66%, indicating strong profitability [2]. - The company's price-to-earnings ratio (P/E) is 73.91, which is lower than the industry average of 103.31, suggesting a potentially favorable valuation compared to peers [2]. Institutional Ratings - Over the past 90 days, 24 institutions have rated the stock, with 17 buy ratings and 7 hold ratings, indicating strong institutional confidence in the company's future performance [3]. - The average target price set by institutions for the stock is 176.35 yuan, suggesting a potential upside from the current trading price [3].

UIH-股票行情快报:联影医疗(688271)1月26日主力资金净买入1.04亿元 - Reportify